Alzheimer’s Nonprofit, Pfizer, Johns Hopkins Partnering on Therapy Development

Alzheimer’s Nonprofit, Pfizer, Johns Hopkins Partnering on Therapy Development
The Alzheimer's Drug Discovery Foundation and Pfizer's Centers for Therapeutic Innovation are  supporting a Johns Hopkins University School of Medicine effort to develop therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases. Valina Dawson, a neurology professor who is co-director of neuroregeneration and stem cell programs at Johns Hopkins' Institute for Cell Engineering, will lead the project. The goal of the collaboration "is to find the most promising new targets for treating Alzheimer's and Parkinson's and develop potential medicines against them as quickly as possible to the benefit of patients," Dr. Uwe Scho
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *